REQUEST A DEMO
Total
USD $0.00
Search more companies

Mab Pharma Zrt. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Mab Pharma Gyogyszergyarto es Kereskedelmi Zrt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Mab Pharma Gyogyszergyarto es Kereskedelmi Zrt is a pharmaceutical company with operations in foreign trade activities, distribution, and registration of licensed products in cooperation with innovative pharmaceutical manufacturers. The company is committed to market distribution of high-quality, price-competitive medicines and preparations. Mab Pharma Zrt supports energy management and waste monitoring.

Headquarters
Torbagy utca 24.
Torokbalint; Pest; Postal Code: 2045

Contact Details: Purchase the Mab Pharma Zrt. report to view the information.

Website: http://www.mab-pharma.hu

Basic Information
Total Employees:
Purchase the Mab Pharma Zrt. report to view the information.
Outstanding Shares:
Purchase the Mab Pharma Zrt. report to view the information.
Registered Capital:
Purchase the Mab Pharma Zrt. report to view the information.
Financial Auditors:
Purchase the Mab Pharma Zrt. report to view the information.
Incorporation Date:
February 27, 2012
Key Executives
Purchase this report to view the information.
Member of Board of Directors
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Mab Pharma Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
27.46%
Total operating revenue
30.14%
Operating profit (EBIT)
-82.72%
EBITDA
-20.32%
Net Profit (Loss) for the Period
-53.75%
Total assets
20.25%
Total equity
13.92%
Operating Profit Margin (ROS)
-7.76%
Net Profit Margin
-7.21%
Return on Equity (ROE)
-8.67%
Debt to Equity Ratio
0.28%
Quick Ratio
-0.09%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?